NOTIFICATION OF TRADE AMONG PRIMARY INSIDERS

DiaGenic announced a firm placing of new shares on 8 July 2009. Mandatory notification of trade among primary insiders of DiaGenic ASA took place in the placing. The transactions increased the net exposure among the insiders by 130,000 shares. The transactions are described in more detail below. Håkon Sæterøy, Executive Chairman of the Board of DiaGenic ASA, has subscribed for 43,000 shares in this placing at NOK 3.74 per share. Sæterøy`s overall exposure in the Company has increased to a total of 1,386,478 shares post the placing. Gustav Ingemar Kihlström, Deputy Chairman of the Board of DiaGenic ASA, has subscribed for 10,000 shares in this placing at NOK 3.74 per share. Kihlström`s overall exposure in the Company has increased to a total of 105,000 shares post the placing. Erik Christensen, Chief Executive Officer in DiaGenic ASA, has subscribed for 20,000 shares in this placing at NOK 3.74 per share. Christensen`s overall exposure in the Company has increased to a total of 150,000 shares post the placing. Praveen Sharma, Director and board member in DiaGenic ASA, has subscribed for 10,000 shares in this placing at NOK 3.74 per share. Sharma`s overall exposure in the Company has increased to a total of 2,995,000 shares post the placing. Anders Lönneborg, Director in DiaGenic ASA, has subscribed for 10,000 shares in this placing at NOK 3.74 per share. Lönneborg`s overall exposure in the Company has increased to a total of 2,900,000 shares post the placing. Morten Sten Johansen, Director in DiaGenic ASA, has subscribed for 20,000 shares in this placing at NOK 3.74 per share. Johansen`s overall exposure in the Company has increased to a total of 140,000 shares post the placing. Mina Blair, board member in DiaGenic ASA, has subscribed for 7,000 shares in this placing at NOK 3.74 per share. Blair`s overall exposure in the Company has increased to a total of 7,000 shares post the placing. Ruben Ekbråten, Financial Controller in DiaGenic ASA, has subscribed for 10,000 shares in this placing at NOK 3.74 per share. Ekbråten`s overall exposure in the Company has increased to a total of 10,000 shares post the placing. Contact: MD PhD Erik Christensen, Managing Director Telephone: +47 95939918 e-mail: erik.christensen@diagenic.com